PyInvesting

Market research

BSL.SG RAFFLES MEDICAL GROUP LTD

SG SGD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
2B
P/E ratio
21.62
Analyst target
1.05
Dividend yield
3.5%
Beta
0.21

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Raffles Medical Group Ltd is currently in a long term uptrend where the price is trading 17.1% above its 200 day moving average.

From a valuation standpoint, the stock is 55.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.8.

Raffles Medical Group Ltd's total revenue rose by 317.0% to $568M since the same quarter in the previous year.

Its net income has increased by 251.5% to $66M since the same quarter in the previous year.

Finally, its free cash flow grew by 81.6% to $-11M since the same quarter in the previous year.

Based on the above factors, Raffles Medical Group Ltd gets an overall score of 5/5.